Cygna Labs has entered into a definitive agreement to acquire NCC Group’s DDI business. The acquisition includes the purchase of the DDI Guard™ product, the portfolio of DDI customers, and NCC Group’s team of DDI experts. Cygna Labs was supported by the private equity company INVISION, which has a majority stake in the Miami-based company. Cygna Labs is a highly specialized software developer with a focus on serving enterprises worldwide and a leading provider of DDI, cloud security, and compliance technology. With the acquisition of NCC Group’s DDI business, Cygna Labs establishes its presence in the UK and further strengthens its intellectual property.
NCC Group is a global cyber and software resilience business operating across multiple sectors, geographies, and technologies. With a significant market presence in the UK, Europe, and North America, and a growing footprint in Asia Pacific, the company works with organizations to assess, develop and manage their cyber resilience posture to enable them to take advantage of the opportunities that sustain their business growth.
Cygna Labs is a software developer and one of the top three global DDI vendors. Many Fortune 100 customers rely on Cygna Labs’ DDI products and services, in addition to its industry-leading security and compliance solutions, to detect and proactively mitigate data security threats, affordably pass compliance audits, and increase the productivity of their IT departments.
The acquisition of NCC Group’s DDI business is a very important step for Cygna Labs as it establishes its UK presence and expands its team of highly specialized DDI experts who will serve many large UK-based and global enterprise organizations. The addition of DDI Guard to its intellectual property will ensure a seamless integration for NCC Group customers while strengthening its team to help better serve its global client base.
“Bringing together Cygna Labs’ innovative spirit and the power of our global footprint with the expertise of the NCC Group’s DDI team will benefit our existing and new customers”, says Alexander Häcker (CEO, Cygna Labs Group GmbH). “The team from NCC will become part of the N3K team, a wholly-owned subsidiary of Cygna Labs Group. We are committed to ensuring streamlined processes, agility, and the tools needed to enhance our independent full DDI-managed service offering.” Christian Ehrenthal, CEO of Cygna Labs Corp., adds: “As we continue our trajectory towards expanding our reach to the UK market, this acquisition not only brings us closer to fulfilling our mission of providing a seamless approach to security and compliance solutions but extends our market presence, a key objective for Cygna Labs. We are thrilled to expand our product portfolio and, in turn, provide our customers with the best in DDI services and support.”
About INVISION
Since its foundation in 1997, INVISION has successfully developed into one of Europe’s leading investors for succession solutions and growth financing for medium-sized companies. During this time, INVISION has invested more than EUR 1 billion in over 60 companies and achieved sustainable valuation creation. INVISION acts as an entrepreneurial partner to entrepreneurs and management teams. As part of its growth levers, INVISION seeks to internationalize businesses, introduce new products and services as well as catalyze the internal digitalization process.
Further information can be found on www.invision.ch
Media contacts
INVISION BETEILIGUNGSBERATUNG GMBH
Grünstrasse 23
40212 Düsseldorf / Germany
Tel. +49 211 936 727 50 E-Mail: info@invision.ch
www.invision.ch
